Frequencies of different behaviours (Compartment Changes, Escape Attempts, Stimulus Orientation, Stimulus Approach, Stimulus Contact, Grunting, Barking, Excretion), the minimum dis... by Sara Hintze (3216885)

Subjects:

Image 3_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif by Nana Wang (533812)

Image 2_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.tif by Nana Wang (533812)

Image 1_Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma.jpeg by Nana Wang (533812)

Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28). by Kendall M. Coden (18516237)

“…Expression of 7 proteins significantly correlated with stereotypy severity in CD1 mice. …”

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

Subjects:

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Results of RF regression model validation and significance of influencing factors (desert area change and spatiotemporal characteristics of ERI). by Mingyue Sun (4638535)

(a) Average absolute percentage relative error (AAPRE), and, (b) Coefficient of determination (R²) of the models. by Fahd Saeed Alakbari (10701871)

Subjects:

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Subjects:

PRISMA flowchart of the article selection process. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of hypothyroidism (=event) among pediatric brain cancer patients treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the odds of 5-year overall-survival rate among children with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Data_table_with_all_identified_articles_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of grade 3 anemia (=event) among pediatric patients with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects: